Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis

Oral submucous fibrosis (OSMF) is considered a premalignant condition characterized by aggressive fibrosis of the submucosal tissues of the oral cavity reflecting its malignant transformation potential. Activation of transforming growth factor beta (TGF-β) signaling has been reported to lead increas...

Descripción completa

Detalles Bibliográficos
Autor principal: Boreak, Nezar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035005/
https://www.ncbi.nlm.nih.gov/pubmed/33869629
http://dx.doi.org/10.1155/2021/6631848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035005/
https://www.ncbi.nlm.nih.gov/pubmed/33869629
http://dx.doi.org/10.1155/2021/6631848

Ejemplares similares